SCHEMBL1787845

SCHEMBL1787845

O=Cc1cccc2c(=O)c3cc(O)ccc3oc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.59
ESR2 Q92731 4/20 0.56
ESR1 P03372 3/20 0.56
DHFR P00374 1/20 0.48
CYP1A2 P05177 1/20 0.48
KCNH2 Q12809 1/20 0.48
TTR P02766 1/20 0.45
CYP3A4 P08684 2/20 0.44
MAPT P10636 2/20 0.44
MGAM O43451 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
CYP2C9 P11712 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
FASN P49327 1/20 0.44
SNCA P37840 1/20 0.44
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
PTPN1 P18031 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13630709 0.82 MAOA (0.60) MAOACYP3A4MAPTKDM4EHSD17B10
SCHEMBL17820117 0.79 MAOA (0.62) MAOAESR2ESR1DHFRCYP1A2
Euxanthone SCHEMBL2161295 0.76 MAOA (0.81) MAOAESR2ESR1DHFRCYP1A2
Xanthone SCHEMBL29025600 0.75 MAOA (1.00) MAOAESR2ESR1TTRCYP3A4
SCHEMBL1675981 0.75 MAOA (1.00) MAOAESR2ESR1TTRCYP3A4
SCHEMBL30599042 0.75 MAOA (1.00) MAOAESR2ESR1TTRCYP3A4
SCHEMBL787917 0.73 MAOA (0.44) MAOACYP3A4MAPTKDM4EMEN1
SCHEMBL5319348 0.72 AHR (0.51) KMT2APTPN1ALDH1A1
SCHEMBL22511380 0.71 TTR (0.54) TTRMAPTKDM4EMEN1KMT2A
SCHEMBL23707495 0.71 PTPN1 (0.67) MAOAMAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8323750-B2 Method of ultraviolet light assisted surface modification and product having a surface formed by this method BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) 2012-12-04 US disclosed
US-20110124766-A1 METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124766-A1 METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD XPA, CYBA, PROC MAOA 34/4885ESR2 1749/4885ESR1 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.